Latest Schedule 13G passive stakes

Four entities have filed a Schedule 13G disclosing a combined 57.59% beneficial ownership stake in WeShop Holdings Ltd.

Red Oak Partners and David Sandberg have filed a Schedule 13G reporting a 5.5% beneficial ownership stake in Motorsport Games Inc.

Inventive Sino Limited and Zhenhua Wang have filed a Schedule 13G reporting a 4.7% beneficial ownership stake in BuzzFeed Inc.

Individual investor Matthew James Schad reports a 0.17% beneficial ownership stake in Hub Cyber Security Ltd.

Inventive Sino Limited and Zhenhua Wang have filed a Schedule 13G disclosing a 5.6% beneficial ownership stake in BuzzFeed, Inc.

Space Summit Capital LLC has filed a Schedule 13G reporting a 6.5% beneficial ownership stake in Aeon Acquisition I Corp.

Individual investor Aymen Shaibatalhamd has filed an amendment reporting a 5.9% beneficial ownership stake in CorMedix Inc.

Individual investor Aymen Shaibatalhamd has filed an amended Schedule 13G reporting a 5.9% beneficial ownership stake in CorMedix Inc.

Ryan Taylor filed a Schedule 13G amendment disclosing zero beneficial ownership of Ascent Solar Technologies, Inc. common stock.

Trillium Trading, LLC has filed an amendment to its Schedule 13G, reporting that it no longer beneficially owns any shares of Rubico Inc.

Devon Xin Xu and Sandie Gong have sold their entire 100,000-share position in Aditxt, Inc., reducing their ownership to zero.

Sandie Gong and Devon Xu disclosed a significant 12.3% ownership stake in Aditxt, Inc. before immediately disposing of their entire position.

DeepCurrents Investment Group LLC and affiliates have reported a 7.7% beneficial ownership stake in Gossamer Bio, Inc. via a Schedule 13G filing.

TCG Crossover Fund II and III, led by Chen Yu, have collectively reported a 5.3% beneficial ownership stake in Zai Lab Limited.

The S&G Foundation has filed a Schedule 13G reporting a 5.3% beneficial ownership stake in Infleqtion, Inc. common stock.

Investment firm Pertento Partners LLP and affiliates have reported a 5% beneficial ownership stake in Sonida Senior Living, Inc. common stock.

Millennium Management and affiliated entities have reported a 5.4% beneficial ownership stake in Once Upon a Farm, PBC.

Sculptor Capital LP and affiliated entities have reported a 5.8% beneficial ownership stake in Long Table Growth Corp.

683 Capital Management, LLC and Ari Zweiman have reported a 9.99% beneficial ownership stake in Gossamer Bio, Inc. as of June 11, 2026.

Agustin Diaz Rodriguez has filed a Schedule 13G disclosing a 13.82% beneficial ownership stake in Aditxt, Inc.

Leviticus Partners LP has increased its beneficial ownership of Maris Tech Ltd. common stock to 8.6%, holding 830,972 shares.

Feis Equities LLC and Lawrence M. Feis have jointly reported beneficial ownership of 803,940 Class A ordinary shares, representing 5.59% of the outstanding shares, in Aeon Acquisition I Corp.

Filers report a combined 10.09% stake in Palmer Square Capital BDC Inc. following an amendment to correct entity identification.

A joint filing reveals that WBT VALUE LIMITED, LUCKY SEASON LIMITED, LUCKY SEASON TRUST, and Zheyu Huang collectively hold a 10.01% stake in Canada Goose Holdings Inc.'s Subordinate Voting Shares.

Trillium Trading, LLC has reported beneficial ownership of 175,000 Class A Ordinary Shares, representing 5.4% of the outstanding shares, in Rubico Inc.

Linden Capital L.P. and affiliated entities have filed a Schedule 13G, reporting beneficial ownership of 5.0% to 5.2% of Long Table Growth Corp.'s Class A Ordinary Shares.

Iroquois Capital Management LLC, Richard Abbe, and Kimberly Page have collectively reported beneficial ownership of 5.14% of XWELL, Inc. common stock as of June 1, 2026.

Merus Global Investments, LLC has filed a Schedule 13G reporting a 5.1% beneficial ownership stake in D. Boral ARC Acquisition I Corp.

Harraden Circle Investments and affiliated entities have reported an 8.77% beneficial ownership stake in Aeon Acquisition I Corp.

Tang Capital Management and Kevin Tang have reported an 8.2% beneficial ownership stake in Fulcrum Therapeutics, Inc. via a Schedule 13G filing.